Vidović A - Search Results

1

Dipeptidyl peptidase IV: serum activity and expression on lymphocytes in different hematological malignancies.

Matić IZ, Đorđević M, Đorđić M, Grozdanić N, Damjanović A, Kolundžija B, Vidović A, Bila J, Ristić S, Mihaljević B, Tomin D, Milanović N, Ristić D, Purić M, Gavrilović D, Cordero OJ, Juranić ZD. Matić IZ, et al. Among authors: vidovic a. Leuk Lymphoma. 2013 Dec;54(12):2701-6. doi: 10.3109/10428194.2013.782611. Epub 2013 Apr 19. Leuk Lymphoma. 2013. PMID: 23469960

2

Effect of all-trans-retinoic acid alone or in combination with chemotherapy in newly diagnosed acute promyelocytic leukaemia.

Colović MD, Janković GM, Elezović I, Vidović A, Bila JS, Novak A, Babić D. Colović MD, et al. Among authors: vidovic a. Med Oncol. 1997 Jun;14(2):65-72. doi: 10.1007/BF02990950. Med Oncol. 1997. PMID: 9330265 Clinical Trial.

3

[T-cell-rich B-cell lymphoma].

Vidović A, Tomin D, Cemerikić V, Milivojević G, Colović M. Vidović A, et al. Srp Arh Celok Lek. 2000 Mar-Apr;128(3-4):116-9. Srp Arh Celok Lek. 2000. PMID: 10932621 Serbian.

4

The proto-oncogene expression varies over the course of chronic myeloid leukemia.

Vidović A, Janković G, Colović M, Tomin D, Perunicić M, Bila J, Marković O, Bosković D. Vidović A, et al. Hematology. 2008 Feb;13(1):34-40. doi: 10.1179/102453308X315807. Hematology. 2008. PMID: 18534064

5

Osteolytic lesions marker in multiple myeloma.

Djunic I, Elezovic I, Marinkovic M, Suvajdzic-Vukovic N, Tomin D, Jankovic G, Bila J, Antic D, Vidovic A, Neskovic B, Nikolic-Vukosavljevic D. Djunic I, et al. Among authors: vidovic a. Med Oncol. 2011 Mar;28(1):237-40. doi: 10.1007/s12032-010-9432-4. Epub 2010 Feb 2. Med Oncol. 2011. PMID: 20127208

6

Mycophenolate mophetil therapy for chronic immune thrombocytopenic purpura resistant to steroids, immunosuppressants, and/or splenectomy in adults.

Colović M, Suvajdzic N, Colović N, Tomin D, Vidović A, Palibrk V. Colović M, et al. Among authors: vidovic a. Platelets. 2011;22(2):153-6. doi: 10.3109/09537104.2010.520372. Epub 2010 Dec 8. Platelets. 2011. PMID: 21142405 Clinical Trial.

7

Central nervous system relapse in CD56+, FLT3/ITD+ promyelocytic leukemia.

Colovic N, Tomin D, Vidovic A, Tosic N, Atkinson HD, Colovic MD. Colovic N, et al. Among authors: vidovic a. Med Oncol. 2012 Mar;29(1):260-2. doi: 10.1007/s12032-011-9834-y. Epub 2011 Feb 5. Med Oncol. 2012. PMID: 21298367

8

Comorbidity as a risk factor for overall survival and decision criteria for intensity of chemotherapy in elderly patients with acute myeloid leukemia.

Djunic I, Virijevic M, Novkovic A, Djurasinovic V, Colovic N, Vidovic A, Suvajdzic-Vukovic N, Tomin D. Djunic I, et al. Among authors: vidovic a. Med Oncol. 2012 Jun;29(2):1077-81. doi: 10.1007/s12032-011-9853-8. Epub 2011 Feb 18. Med Oncol. 2012. PMID: 21331819 Clinical Trial.

9

Acquired von Willebrand syndrome in multiple myeloma.

Djunic I, Elezovic I, Ilic V, Tomin D, Suvajdzic-Vukovic N, Bila J, Antic D, Vidovic A, Milosevic-Jovcic N. Djunic I, et al. Among authors: vidovic a. Hematology. 2011 Jul;16(4):209-12. doi: 10.1179/102453311X12953015767617. Hematology. 2011. PMID: 21756536

10

Prognostic significance of CD56 antigen expression in patients with acute myeloid leukemia.

Djunic I, Virijevic M, Djurasinovic V, Novkovic A, Colovic N, Kraguljac-Kurtovic N, Vidovic A, Suvajdzic-Vukovic N, Tomin D. Djunic I, et al. Among authors: vidovic a. Med Oncol. 2012 Sep;29(3):2077-82. doi: 10.1007/s12032-011-0104-9. Epub 2011 Nov 12. Med Oncol. 2012. PMID: 22081445

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

96 results

Search Page